The Center's Steering Committee (CSC) is the Center’s executive body and establishes its priorities and policies. The CSC consists of five academic and five non-academic members, including the NCI Project Scientist.

Moon S. Chen Moon S. Chen, Jr., Ph.D., M.P.H.
Professor of Internal Medicine
UC Davis and founding Principal Investigator (PI) of AANCART
Tung Nguyen, M.D. Tung Nguyen, M.D.
Professor of Medicine
UC San Francisco
Deputy PI for AANCART
Edward A. Chow, M.D. Edward A. Chow, M.D.
Health Commissioner for the City of San Francisco
Chair, Board of Directors for the Chinese Community Health Resource Center


The Administrative Core is the fulcrum for the Center and provides the leadership structure with its three PIs, program leaders, and organizational infrastructure for AANCART: The National Center and is physically located at the UC Davis Comprehensive Cancer Center, a NCI-designated cancer center.  Included in this Core are the Center Steering Committee and the Community Advisory Committee.  This Core assures synchronization of all activities.

The Community Outreach Program is the vehicle for orchestrating the Center’s health promotion and educational activities.  This Program concentrates its efforts in California and Hawaii and in particular emphasizing Asian Americans of Chinese, Filipino, Hmong, Korean, and Vietnamese ancestry through culturally competent venues in both English and Asian languages.

The Research Program is the engine driving the controlled intervention trial and the pilot study.  Tung Nguyen, M.D., who is also the PI of an R01 with an RCT studying colorectal cancer screening among Chinese Americans, directs our innovative controlled trial involving three Asian American ethnic populations in three sites.  Susan Stewart, Ph.D., AANCART’s Biostatistical Director and Program Evaluator is the co-program director. She provides research design expertise.

The Training Program, led by Marjorie Kagawa-Singer, Ph.D., M.S.N., FAAN of Los Angeles and Shin-Ping Tu, M.D., M.P.H. of Seattle, nurtures new investigators in CBPR.  Drs. Kagawa-Singer and Tu offer complementary expertise in CBPR and R01 experience that enhances the program.